Evaluating Lipid-Lowering Drug Targets for Parkinson's Disease Prevention with Mendelian Randomization. (2020)

First Author: Williams DM
Attributed to:  Physiological resilience: mechanisms and consequences funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/ana.25880

PubMed Identifier: 32841444

Publication URI: http://europepmc.org/abstract/MED/32841444

Type: Journal Article/Review

Volume: 88

Parent Publication: Annals of neurology

Issue: 5

ISSN: 0364-5134